NCT07486518 A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India
| NCT ID | NCT07486518 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Asian Institute of Gastroenterology, India |
| Condition | Gastric Adenocarcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 4,000 participants |
| Start Date | 2026-08-01 |
| Primary Completion | 2028-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 4,000 participants in total. It began in 2026-08-01 with a primary completion date of 2028-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To estimate the prevalence of histologically confirmed early gastric cancer (EGC) in an Indian multicentre cohort undergoing standardised high-quality upper gastrointestinal endoscopy. EGC is defined as gastric adenocarcinoma confined to the mucosa or submucosa (T1), irrespective of lymph node status, based on histopathology.
Eligibility Criteria
1. Adults aged ≥40 years undergoing upper gastrointestinal endoscopy for dyspepsia or other clinical indications (nonalarming and alarming symptoms both). 2. Ability to provide written informed consent. Exclusion Criteria: 1. Known gastric malignancy. 2. Prior gastric surgery (excluding H. pylori eradication). 3. Contraindications to endoscopy or biopsy. 4. Known hereditary gastric cancer syndromes.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07486518 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Gastric Adenocarcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07486518 currently recruiting?
Yes, NCT07486518 is actively recruiting participants. Contact the research team at hardik.hr@gmail.com for enrollment information.
Where is the NCT07486518 trial being conducted?
This trial is being conducted at Hyderabad, India.
Who is sponsoring the NCT07486518 clinical trial?
NCT07486518 is sponsored by Asian Institute of Gastroenterology, India. The trial plans to enroll 4,000 participants.